drugset / Trial / NCT04976088

Clinical Trial With Diclofenac Sodium Medicated Plaster in Patients With Impact Injuries of the Limbs

NCT04976088

Phase 3 Completed 214 enrolled Fidia Farmaceutici s.p.a.
RandomizedParallel-groupDouble-blindTreatment

Summary

Phase III, multinational, multicentre, randomized, prospective, double blind, parallel groups, placebo-controlled study to evaluate the analgesic effects of Test Diclofenac Sodium 140mg medicated plaster, Reference DIEP 180 mg medicated plaster, Flector® and Placebo plaster in patients with painful and phlogistic disease due to acute traumatic events of the limbs.

Timeline

Start
2018-05-25
Primary completion
2018-10-27
Completion
2018-10-27

Drugs

EvaluationDrugModalityDoseRoute
Comparator Diclofenac Other / unclassified 140 mg Topical
Comparator Diclofenac Other / unclassified 180 mg Topical

Indications

No indication recorded.